Castleman’s disease with TAFRO syndrome: The first case from Iran

  • سال انتشار: 1397
  • محل انتشار: هفدهمین کنگره سراسری انجمن مدیکال انکولوژی و هماتولوژی ایران
  • کد COI اختصاصی: ISMOH17_001
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 468
دانلود فایل این مقاله

نویسندگان

Seyede Tahereh Mohaddess

Assistant Professor, Division of hematology oncology, department of internal medicine,Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad ,Iran

Zahra Rezaei Borojerdi

Internal Medicine Resident, Division of Hematology Oncology, Department of Internal Medicine,Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad ,Iran

Abbas Shirdel

Hematology Oncology Fellowship, Division of Hematology Oncology, Department of Internal Medicine,Faculty of Medicine, Mashhad, Iran.

Mohammad Moeini Nodeh

Professor of Hematology and Oncology, Division of Hematology Oncology, Department of InternalMedicine, Faculty of Medicine, Mashhad, Iran

چکیده

Introduction: TAFRO syndrome is new presentation of idiopathic multicentric Castlemandisease which is termed as thrombocytopenia, anasarca, fever, reticulinmyelofibrosis andorganomegaly. The exact pathophysiology of TAFRO syndrome is unclear and management ismostly based on case reports and expert opinion.Materials Methods: Histologic findings of bone marrow, skin, kidney and lymph node biopsyand other laboratory findings of the 37 year old male has been provided.Results: The patient was referred with fever, sweating, anorexia, abdominal distension andgeneralized edema which has been hospitalized multiple times. The patient also developed skinlesions dispersed in red nodules, which was reported as granuloid hemangioma Renal biopsyreported mesangioprolifrative glomerulonephritis and bone marrow specimen showed hypercellularmarrow with reticulin fibrosis. The lymph node biopsy was reported as Castleman disease.Conclusions: Different manifestations of TAFRO syndrome may overlap with other syndromes andcan be managed by corticosteroids, tocilizumab, retuximab, and bortezomib.

کلیدواژه ها

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.